Elizabeth Buck
Founder chez BLACK DIAMOND THERAPEUTICS, INC.
Fortune : 482 623 $ au 31/03/2024
Profil
Elizabeth Buck is the founder and currently holds the position of CSO, EVP-Discovery & Translational Sciences at Black Diamond Therapeutics, Inc., which was founded in 2014.
Prior to her current role, she held the position of Assistant Director-Advanced Preclinical at OSI Pharmaceuticals, Inc. from 2005 to 2013.
She also served as the Chief Scientific Officer-Therapeutics at MetaStat, Inc. from 2013 to 2014.
Dr. Buck completed her undergraduate degree at the University of New Hampshire and obtained a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/02/2024 | 95 192 ( 0,18% ) | 482 623 $ | 31/03/2024 |
Postes actifs de Elizabeth Buck
| Sociétés | Poste | Début |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Founder | 01/01/2014 |
Anciens postes connus de Elizabeth Buck
| Sociétés | Poste | Fin |
|---|---|---|
| METASTAT, INC. | Chief Tech/Sci/R&D Officer | 01/12/2014 |
Formation de Elizabeth Buck
| University of New Hampshire | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
